Skip to content

Phase Resolved Functional Lung MRI and Oscillometry for the Observation of Healthy Lung Function

Phase Resolved Functional Lung MRI and Oscillometry for the Observation of Healthy Lung Function

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07614685
Acronym
PROOF
Enrollment
20
Registered
2026-05-29
Start date
2026-09-01
Completion date
2028-01-01
Last updated
2026-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breathing, Healthy, Lung Function Decreased, MRI Imaging

Brief summary

This study will examine the relationship of airways resistance measured by oscillometry with ventilation defects measured by Phase Resolved Functional Lung (PREFUL) MRI in healthy human subjects.

Interventions

DEVICEAirway Oscillometer

The termoflo c-100 Airwave Oscillometer System is intended to measure respiratory system impedance using the Forced Oscillation Technique (FOT).

DIAGNOSTIC_TESTPhase Resolved Functional Lung MRI

The Phase Resolved Functional Lung (PREFUL) MRI technique acquires images of the lung so that measures of ventilatory defect percentage can be calculated.

Sponsors

University of Rochester
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Age 18 years or older * Ability to provide consent * Willingness to perform MRI and breathing test * Must be able to speak and understand English

Exclusion criteria

* Pregnant * Unable or willing to provide consent or perform the required maneuvers for testing.

Design outcomes

Primary

MeasureTime frameDescription
OscillometerSingle measurement, approximately 1 dayThe oscillometer will collect an airway impedance measurement which is made up of multiple variables.
Phase Resolved Functional Lung (PREFUL) MRISingle measurement, approximately 1 dayPREFUL MRI will acquire images of the lungs and a measurement called the ventilatory defect percentage (or VDP) will be calculated.

Countries

United States

Contacts

CONTACTPatrick Donohue, MD
patrick_donohue@urmc.rochester.edu585-210-9301

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 12, 2026